Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04367597 · ClinicalTrials.gov registry record · NA

Evaluation of NMES Therapy for Pain Relief Associated With Knee Osteoarthritis

A NA study of Knee Osteoarthritis, sponsored by CyMedica Orthopedics.

Completed
Registry status
NA
Development phase
64
Enrollment target
5
Study locations

NCT04367597 is a NA study of Knee Osteoarthritis that has completed, run by CyMedica Orthopedics. The registered enrollment target is 64 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (79% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04367597, a NA study of Knee Osteoarthritis, has completed, sponsored by CyMedica Orthopedics.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target
5
Study locations

Study Summary

A roll-over study of the current CM-2019 trial to assess the same preplanned outcomes of CM-2019 at 14 weeks.

Conditions Studied

Interventions

  • DEVICE Home-based Neuromuscular Electrical Stimulation (NMES) therapy

Study Locations (5)

Texas

  • Synergy Group US LLC - Houston
  • Synergy Group US LLC - Katy
  • Synergy Group US LLC - Missouri City

Arizona

  • Noble Clinical Research - Tucson
  • Tucson Orthopedic Institute - Tucson

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2020-04-20
Est. Completion 2021-03-16
Phase NA

Sponsor

CyMedica Orthopedics

3 total trials

What the Registry Record Tells You About NCT04367597

The ClinicalTrials.gov registry entry for NCT04367597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (79% lower). The listed sponsor is CyMedica Orthopedics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Home-based Neuromuscular Electrical Stimulation (NMES) therapy is the first listed.

NCT04367597 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Texas, Arizona.

Frequently Asked Questions

What is clinical trial NCT04367597 about?

NCT04367597 is a clinical study titled "Evaluation of NMES Therapy for Pain Relief Associated With Knee Osteoarthritis". A roll-over study of the current CM-2019 trial to assess the same preplanned outcomes of CM-2019 at 14 weeks.

What is the current status of trial NCT04367597?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2020-04-20. Estimated completion is 2021-03-16.

What conditions does trial NCT04367597 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT04367597?

The interventions under investigation include: Home-based Neuromuscular Electrical Stimulation (NMES) therapy (DEVICE).

Who is sponsoring clinical trial NCT04367597?

This trial is sponsored by CyMedica Orthopedics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04367597 being conducted?

This trial has 5 study locations across Arizona, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.